ITUA20163025A1 - Composizione per il trattamento della sindrome dell’ovaio policistico - Google Patents

Composizione per il trattamento della sindrome dell’ovaio policistico

Info

Publication number
ITUA20163025A1
ITUA20163025A1 ITUA2016A003025A ITUA20163025A ITUA20163025A1 IT UA20163025 A1 ITUA20163025 A1 IT UA20163025A1 IT UA2016A003025 A ITUA2016A003025 A IT UA2016A003025A IT UA20163025 A ITUA20163025 A IT UA20163025A IT UA20163025 A1 ITUA20163025 A1 IT UA20163025A1
Authority
IT
Italy
Prior art keywords
policistic
treatment
composition
ovarian syndrome
ovarian
Prior art date
Application number
ITUA2016A003025A
Other languages
English (en)
Inventor
Carlo Eigenmann
Leo Vincenzo De
Original Assignee
Sochim Int S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56801695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITUA20163025(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sochim Int S P A filed Critical Sochim Int S P A
Priority to ITUA2016A003025A priority Critical patent/ITUA20163025A1/it
Priority to PCT/IB2017/052430 priority patent/WO2017187375A1/en
Priority to EP17730926.7A priority patent/EP3448370B2/en
Publication of ITUA20163025A1 publication Critical patent/ITUA20163025A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITUA2016A003025A 2016-04-29 2016-04-29 Composizione per il trattamento della sindrome dell’ovaio policistico ITUA20163025A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITUA2016A003025A ITUA20163025A1 (it) 2016-04-29 2016-04-29 Composizione per il trattamento della sindrome dell’ovaio policistico
PCT/IB2017/052430 WO2017187375A1 (en) 2016-04-29 2017-04-27 Composition for the treatment of polycystic ovary syndrome
EP17730926.7A EP3448370B2 (en) 2016-04-29 2017-04-27 Composition for the treatment of polycystic ovary syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A003025A ITUA20163025A1 (it) 2016-04-29 2016-04-29 Composizione per il trattamento della sindrome dell’ovaio policistico

Publications (1)

Publication Number Publication Date
ITUA20163025A1 true ITUA20163025A1 (it) 2017-10-29

Family

ID=56801695

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A003025A ITUA20163025A1 (it) 2016-04-29 2016-04-29 Composizione per il trattamento della sindrome dell’ovaio policistico

Country Status (3)

Country Link
EP (1) EP3448370B2 (it)
IT (1) ITUA20163025A1 (it)
WO (1) WO2017187375A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111655245B (zh) * 2017-11-23 2023-08-08 生物学研究院 提高患有多囊卵巢综合征的雌性受试者的胚胎着床率的方法
WO2019122119A1 (en) * 2017-12-22 2019-06-27 Lo.Li. Pharma International S.R.L. Treatment of fibrosis with inositol

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013016742A1 (en) * 2011-07-22 2013-01-31 Smith Conrad Anton Composition for obesity treatment
WO2013016741A1 (en) * 2011-07-22 2013-01-31 Smith Conrad Anton Dietary supplement for use in a weight loss program

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906979A (en) 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
EP1841440A2 (en) 2004-12-22 2007-10-10 Renaissance Herbs, Inc. Pharmaceutical, therapeutic, and dietary compositions derived from lagerstroemia speciosa l. plant
JP2006213684A (ja) 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
US20090263505A1 (en) 2008-04-21 2009-10-22 George Roderick Hammons Dietary therapeutic compositions for ameliorating disease symptoms and conditions associated with diabetes
US8114445B2 (en) 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same
IT1403587B1 (it) 2010-12-17 2013-10-31 Laborest Italia S P A Composizione per il trattamento di disordini metabolici
ITMI20110445A1 (it) 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
ITFI20120288A1 (it) 2012-12-20 2014-06-21 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo e selenio, sua preparazione ed uso.
ITRM20130655A1 (it) 2013-11-26 2015-05-27 Dicofarm Spa Prodotto a base di una associazione di glucomannano ed inositolo
EP2923701A1 (en) 2014-03-27 2015-09-30 Neopharmed Gentili S.r.l. Formulation for the treatment and control of metabolic syndrome and correlated disorders
CA2945609C (en) 2014-07-29 2023-05-23 Shenzhen Hightide Biopharmaceutical, Ltd. Berberine-ursodeoxycholic salt, method of preparation and application therof
ITUB20155087A1 (it) * 2015-11-05 2017-05-05 Pharmamol Srl Composizione per prevenire o trattare la sindrome dell'ovaio policistico e la sintomatologia correlata

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013016742A1 (en) * 2011-07-22 2013-01-31 Smith Conrad Anton Composition for obesity treatment
WO2013016741A1 (en) * 2011-07-22 2013-01-31 Smith Conrad Anton Dietary supplement for use in a weight loss program

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "AntaGolin combats insulin resistance through multiple pathways of action", 3 January 2017 (2017-01-03), XP055331782, Retrieved from the Internet <URL:http://mnilifestyle.co.za/products/antagolin/> [retrieved on 20170103] *
ANONYMOUS: "Combining science and nature AntaGolin... - Insulin resistance, raising awareness through our journey | Facebook", 15 November 2013 (2013-11-15), XP055331781, Retrieved from the Internet <URL:https://www.facebook.com/InsulinResistanceRaisingAwarenessThroughOurJourney/posts/334934786647039> [retrieved on 20170103] *

Also Published As

Publication number Publication date
EP3448370B1 (en) 2020-10-21
EP3448370B2 (en) 2023-07-12
WO2017187375A1 (en) 2017-11-02
EP3448370A1 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
HRP20251596T1 (hr) Nove upotrebe derivata piperidinil-indola
IL258402B1 (en) Electroporation for obesity or diabetes treatment
LT3594238T (lt) Antikūno kompozicijos, skirtos navikų gydymui
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3524255T3 (da) Sammensætning til behandling af acne
EP3584285A4 (en) ADDITIONAL CURING SILICONE COMPOSITION
DK3488443T3 (da) Udvælgelse af neoepitoper som sygdomsspecifikke mål for terapi med øget virkning
IL282311A (en) Use of reboxetine to treat narcolepsy
PL3573620T3 (pl) Kompozycje do leczenia nadciśnienia
EP3795639A4 (en) POLYIMIDE POWDER COMPOSITION
PL3978074T3 (pl) Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
PL3452012T3 (pl) Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych
DK3638293T5 (da) Sammensætninger til behandling af cancer
CY2024037I1 (el) Χρηση delgocitinib για την θεραπεια χρονιουεκζεματος χεριων
EP3668386C0 (en) MEDITATION ENHANCEMENT
HUE064544T2 (hu) Eljárás kromatográfiai termékek összetételének beállítására
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
KR20180084983A (ko) 암의 치료를 위한 피리미도-피리미다지논의 용도
EP3312212A4 (en) Curable composition
ITUA20161990A1 (it) Mangiatoia per avicoltura
HUE063820T2 (hu) Módszerek kardiovaszkuláris betegségek kezelésére
PL3697399T3 (pl) Środki terapeutyczne do zastosowania w leczeniu zespołu niespokojnych nóg
HUE055927T2 (hu) Szubsztrátumkezelõ szerkezet
HUE053924T2 (hu) Kompozíció cukorbetegség kezelésére